New magnetic resonance imaging contrast agents for infarct imaging based on phosphonate derivatives of Gd-DTPA.
Adzamli
I K
IK
Department of Radiology, University of Massachusetts Medical Center, Worcester.
Blau
M
M
Pfeffer
M A
MA
Davis
M A
MA
D000818:Animals; D003287:Contrast Media / Q000633:toxicity; D004164:Diphosphonates / Q000633:toxicity; D004353:Drug Evaluation, Preclinical; D005682:Gadolinium / Q000633:toxicity; D019786:Gadolinium DTPA; D066298:In Vitro Techniques; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009203:Myocardial Infarction / Q000175:diagnosis*; D009206:Myocardium / Q000473:pathology; D009942:Organometallic Compounds / Q000633:toxicity; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000633:toxicity; D011437:Propylamines / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains
D003287:Contrast Media; D004164:Diphosphonates; D009942:Organometallic Compounds; D011437:Propylamines; C069494:DTPA-1-hydroxy-3-aminopropane-1,1-diphosphonate; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA; C011649:3-aminopropylphosphonic acid